LNT purchases prime development site in Gloucester

Image, LNT Construction
A development site in Brockworth, Gloucester, has been sold with full planning consent for a 66-bedroom care home.
The 1.84-acre site is 9.3km from Gloucester city centre, at the eastern gateway to the town, and a short distance from the affluent Cotswolds Area of Outstanding Natural Beauty.
Recognising the location’s excellent potential for elderly care, Aspire LPP submitted a planning application in February 2024, which was granted in February this year.
The consented care home development comprises 66 bedrooms with 100% ensuite wetrooms.
It will also benefit from communal spaces and facilities, including a choice of day spaces and secure landscaped gardens.
Following a sales process run by Sara Hartill at Christie & Co, the site has been sold to LNT Care Developments.
Chris Podd, operations director at Aspire, said: “This care home will help address the significant shortfall in market standard care beds within the Gloucester area.
“Having taken this project through the planning process, it’s great to hand it over to a developer which we know is as committed as we are to providing care spaces which are fit for purpose.
“The site forms part of an exciting pipeline at Aspire of 1,000 beds to be brought to market in 2025.”
Keeley Sharp, land director at LNT Care Developments, added: “Construction has now commenced and we look forward to the home’s opening in Summer 2026.
“This addition in Gloucester sits within an established operating region for our group, providing much-needed residential and dementia care to the local community.”
Hartill said the deal was evidence of increasing interest in sites in areas where there is a shortfall of care beds.
She added: “This new care home will assist in providing excellent elderly healthcare for the immediate and surrounding area and we look forward to continuing our work with Aspire LPP as it brings forward additional healthcare development opportunities across the UK.”
The site was sold for an undisclosed price.